In this episode, Greg McGarrell sits down with Dr. Mark Bowen, an equine internal medicine specialist, to explore a groundbreaking approach to managing equine asthma. Moving beyond traditional treatments like clenbuterol and corticosteroids, Mark shares how a biologic derived from the horse’s own blood is offering a promising alternative — especially for competition horses where drug regulations are tight.

They discuss the origins of equine asthma as a diagnosis, the limitations of conventional therapies, and how biologics might serve as a safer, drug-free anti-inflammatory option. With real-world examples, delivery protocols, and an honest look at what science can and can’t yet explain, this episode dives deep into the future of respiratory care in horses.

Whether you treat performance horses, manage yard favourites, or simply want a glimpse of where respiratory medicine is heading, this conversation delivers practical insight—and plenty to think about.

Have a question or referral? Contact Dr Bowen at referrals@medicine.vet or +44 (0)115 647 0660.

Editors Note: A small correction to this podcast is that Ciclesonide has a 120 hour urine detection time not 72 hours as discussed.